So Far This Year, Health Catalyst Inc. (HCAT) Reached A New High 3 times

At the last check on Friday, Health Catalyst Inc.’s (NASDAQ:HCAT) stock was down -$6.04, moving down -33.06 percent to $12.23. The average number of shares traded per day over the past five days has been 1,301,521 shares. 3 times new highs have been achieved over the past 5 days, with a -$4.72 fall in that time frame. In the last twenty days, the average volume was 847,745, while in the previous 50 days, it was 916,014.

Since last month, HCAT stock rose 13.06%. Shares of the company fell to $11.00 on 08/05/22, the lowest level in the past month. A 52-week high of $59.50 was reached on 01/03/22 after having rallying from a 52-week low of $11.25. Since the beginning of this year, HCAT’s stock price has dropped by -53.89% or -$27.60, and marked a new high 1 time. However, the stock has declined by -79.45% since its 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Health Catalyst Inc. (HCAT) last reported insider trading activity 21 days ago on Jul 15. Llewelyn Linda, the Chief People Officer of the company, disposed of 648 shares for $16.06 on Jul 15. It resulted in a $10,407 divestment by the insider. Llewelyn Linda sold 648 shares at an average price of $12.20 on Jun 15. The insider now owns 58,677 shares following the transaction. On Jun 06, General Counsel Orenstein Daniel H. sold 2,838 shares at $14.85 apiece. The transaction was valued at $42,140.

Financial Health

In the three months ended March 30, Health Catalyst Inc.’s quick ratio stood at 5.20, while its current ratio was 5.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.47. On the profitability front, the trailing twelve-month gross margin is 48.70% percent. In the year ended March 30, operating margins totaled -56.60%. Based on annual data, HCAT earned $117.57 million in gross profit and brought in $241.93 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -19.50%. Return on equity (ROE) for the past 12 months was -32.20%.

In Health Catalyst Inc.’s quarter-end financial report for March 30, it reported total debt of $225.4 million against cash and short-term investments of $226.99 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. HCAT’s revenue rose 17.98% to $64.72 million during the quarter, while net income inched up to $68.09 million. While analysts expected Health Catalyst Inc. to report -$0.11 quarterly earnings, the actual figure was -$0.06 per share, beating the consensus estimate by 45.50%. During the quarter, the company generated -$12.32 million in EBITDA. The liabilities of Health Catalyst Inc. were 344.01 million at the end of its most recent quarter ended March 30, and its total debt was $248.41 million. The value of shareholders’ equity is $54.19 million.

Technical Picture

This quick technical analysis looks at Health Catalyst Inc.’s (HCAT) price momentum. With a historical volatility rate of 216.84%, the RSI 9-day stood at 25.40% on 04 August.

With respect to its five-day moving average, the current Health Catalyst Inc. price is down by -28.23% percent or -$4.72. At present, HCAT shares trade -28.40% below its 20-day simple moving average and -41.87% percent below its 100-day simple moving average. However, the stock is currently trading approximately -12.36% below its SMA50 and -75.93% below its SMA200.

Stochastic coefficient K was 67.04% and Stochastic coefficient D was 82.33%, while ATR was 1.60. Given the Stochastic reading of 13.90% for the 14-day period, the RSI (14) reading has been calculated as 32.14%. As of today, the MACD Oscillator reading stands at -0.35, while the 14-day reading stands at -0.22.

Analyst Ratings

Health Catalyst Inc. downgraded its rating on Health Catalyst Inc. (NASDAQ: HCAT) to a Hold in a note to investors on August 05, 2022. The analysts firm previously had a Buy rating on the stock.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles